GM maize to tackle HIV
Genetically modified (GM) maize is the most effective biomanufacturing platform for the production of monoclonal antibodies to combat HIV, according to research published in PNAS.
Archives for May 28, 2008
GVK BIO secures Wyeth deal
India's GVK BIO has secured a new research agreement with drug giant Wyeth Pharmaceuticals, as more and more pharma firms are relying on outside partners for drug discovery innovations.
Nigerian counterfeit drug seizure
A 20ft container of counterfeit pharmaceuticals has been impounded by the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC).
Water the key to green pharmaceutical manufacturing
Adoption of a new chemical technique could make manufacturing a drug considerably more "green", according to research in Angewandte Chemie.
MDS Pharma Services, Almac Clinical Technologies and Pharm-Olam International – Clinical contract news
Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late, involving MDS Pharma Services, Almac Clinical Technologies and Pharm-Olam International.